Key result
Mitochondria-targeted nanoformulated Chuanxiong extract promotes myocardial recovery and reduces infarct injury after MI.
Why the study?
Does Chuanxiong extract loaded into amino-functionalized mesoporous silica attenuate infarct injury and support heart recovery after myocardial infarction?
Does Chuanxiong extract loaded into amino-functionalized mesoporous silica attenuate infarct injury and support heart recovery after myocardial infarction?
Chuanxiong extract loaded into amino-functionalized mesoporous silica provides mitochondrial-targeting capability to attenuate infarct injury and support heart recovery after myocardial infarction.
Answers are grounded in this paper and cite their sources.
May inform mitochondrial-targeted nanomedicine development for MI; leaves open clinical translation pending human trials.
Mitochondrial Targeting This cover image bridges ancient wisdom and modern science, depicting an ancient Chinese physician alongside a contemporary chemist. It visualizes the Chuanxiong extract loaded into amino-functionalized mesoporous silica unexpectedly confers mitochondrial-targeting capability, enabling targeted protection to support heart recovery after myocardial infarction. This synergy offers a paradigm for dissecting TCM's multitarget pharmacology through organelle-specific delivery. More details can be found in the Research Article by Leyu Wang, Renjie Qiu, and co-workers (DOI: 10.1002/adhm.71579).
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) studied Myocardial infarction. Chuanxiong extract loaded into amino-functionalized mesoporous silica nanocarriers was evaluated on Heart recovery and infarct injury attenuation. Chuanxiong extract loaded into amino-functionalized mesoporous silica confers mitochondrial-targeting capability to support heart recovery after myocardial infarction.
Synapse has enriched 10 related papers. Consider them for comparative context: